ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves EYLEA? americanpharmaceuticalreview
May 15, 2019Regeneron has announced the U.S. Food and Drug Administration (FDA) has approved EYLEA? (aflibercept) Injection to treat all stages of diabetic retinopathy (DR) which helps to reduce the risk of blindness.
Pharma Sources Insight January 2025
